Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[F-18]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET
机构:[a]Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361005, China[b]Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China医技科室核医学科首都医科大学附属安贞医院[c]Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China[d]Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China[e]PET Center, Xuanwu Hospital of Capital University of Medical Sciences, Beijing 100053, China首都医科大学宣武医院
This study reports the synthesis and characterization of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[F-18]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone ([F-18]Fmp2) for myocardial perfusion imaging (MPI). The tosylate precursor and non-radioactive compound [F-19]Fmp2 were synthesized and characterized by infrared, H-1-NMR, C-13-NMR, and mass spectra (MS). The radiotracer [F-18]Fmp2 was obtained by one-step nucleophilic substitution of tosyl with F-18, and evaluated as an MPI agent in vitro and in vivo. Starting from [F-18]KF/K-222 solution, the typical decay-corrected radiochemical yield (RCY) was 38 +/- 8.8% with high radiochemical purity (>98%). The specific activity was calculated as 10GBq/mu mol at the end of synthesis determined by HPLC analysis. In the mice biodistribution, [F-18]Fmp2 showed very high initial heart uptake (53.35 +/- 5.47 %ID/g at 2min after injection) and remarkable retention. The heart/liver, heart/lung, and heart/blood ratios were 7.98, 8.20, and 53.13, respectively at 2min post-injection. In the Positron Emission Tomography (PET) imaging study of Chinese mini-swine, the standardized uptake value of the liver decreased modestly during the 2h post-injection, while the heart uptake and heart/liver ratios continued to increase with time. [F-18]Fmp2 exhibited good stability, high heart uptake and low lung uptake in mice and Chinese mini-swine. It may be worthy of further modification to improve liver clearance for MPI in the future.
基金:
the National Natural Science Foundation of China (81471707, 81301251, 81271613)
the Fundamental Research Funds for the Central Universities (20720150063).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类|4 区医学
小类|4 区生化研究方法4 区分析化学4 区药物化学
最新[2023]版:
大类|4 区医学
小类|4 区生化研究方法4 区分析化学4 区药物化学
JCR分区:
出版当年[2013]版:
Q3CHEMISTRY, ANALYTICALQ4CHEMISTRY, MEDICINALQ4BIOCHEMICAL RESEARCH METHODS
最新[2023]版:
Q4BIOCHEMICAL RESEARCH METHODSQ4CHEMISTRY, ANALYTICALQ4CHEMISTRY, MEDICINAL
第一作者机构:[a]Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361005, China[b]Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
共同第一作者:
通讯作者:
通讯机构:[a]Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361005, China[c]Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China[*1]School of Public Health, Xiamen University, Xiang’an South Rd., Xiang’an district, Xiamen 361102, China
推荐引用方式(GB/T 7714):
Tiantian Mou ,Zuoquan Zhao ,Linyi You ,et al.Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[F-18]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET[J].JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS.2015,58(8):349-354.doi:10.1002/jlcr.3310.
APA:
Tiantian Mou,,Zuoquan Zhao,,Linyi You,,Qian Wang,,Wei Fang,...&Xianzhong Zhang.(2015).Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[F-18]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET.JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS,58,(8)
MLA:
Tiantian Mou,,et al."Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[F-18]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET".JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 58..8(2015):349-354